| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 405 / 669 | 39th | Q3 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Future Rare Diseases
Future Rare Diseases is Scopus-indexed (Q3, CiteScore 0.8), DOAJ. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 2399-5270Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: Checking DOAJ for article charges…
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Future Rare Diseases indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q3, CiteScore 0.8.
What quartile is Future Rare Diseases in Scopus?
Future Rare Diseases is Q3 in Medicine (all) (rank 405 of 669), by CiteScore 2025.
What is the impact factor of Future Rare Diseases?
Future Rare Diseases is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.8, quartile Q3, 39th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.150, quartile Q4, with an H-index of 6.
Who publishes Future Rare Diseases and what is its ISSN?
Future Rare Diseases is published by Taylor and Francis Ltd. Its ISSN is 2399-5270.
Is Future Rare Diseases in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Future Rare Diseases open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Future Rare Diseases? — open metrics via OpenAlex
Future Rare Diseases has an h-index of 7 and a 2-year mean of 0.31 citations per paper (OpenAlex). Its Scopus CiteScore is 0.8, quartile Q3. On 2-year citations it ranks #421 of 646 Scopus journals in Medicine (all).
Future Rare Diseases published 47 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Future Rare Diseases? — latest 98 articles, 2023–2026
In its latest 98 research articles (2023–2026), authors are most often from United States (44.9%), United Kingdom (10.3%) and Germany (7.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Future Rare Diseases? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.